TSLP and asthma: Studies of ILC2 sensitivity toward corticosteroid treatment, which is the mainstay therapy for asthma, showed that thymic stromal lymphopoietin (TSLP)/signal transducer and activator of transcription 5 (STAT5) signaling mediated steroid resistance in ILC2s22.